Evidence map›Paper›PMID 35277541›Full record

ArticleScientific reports2022

Genetic analysis of the cold-sensitive growth phenotype of Burkholderia pseudomallei/thailandensis bacteriophage AMP1.

Andrey V Letarov, Maria A Letarova, Pavel A Ivanov, Ilya S Belalov, Martha R J Clokie, Edouard E Galyov

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Microorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Andrey V LetarovWinogradsky Institute of Microbiology RC Biotechnology RAS, Moscow, Russia. letarov@gmail.com.
Maria A LetarovaWinogradsky Institute of Microbiology RC Biotechnology RAS, Moscow, Russia.
Pavel A IvanovWinogradsky Institute of Microbiology RC Biotechnology RAS, Moscow, Russia.
Ilya S BelalovWinogradsky Institute of Microbiology RC Biotechnology RAS, Moscow, Russia.
Martha R J ClokieDepartment of Genetics and Genome Biology, University of Leicester, Leicester, UK.
Edouard E GalyovDepartment of Genetics and Genome Biology, University of Leicester, Leicester, UK. eg98@leicester.ac.uk.
All-Russian Scientific Research Institute of Food Biotechnology · RUUniversity of Leicester · GB

Funding

Wellcome TrustWellcome Trust 092638/Z/10/Z
6 · The paper itself

Abstract

Bacteriophages related to phage Bp_AMP1 are the most widely spread group of phages infecting Burkholderia pseudomallei-the causative agent of melioidosis. These viruses are also infective against the nonpathogenic host Burkholderia thailandensis, allowing experimental work with them without any special safety precautions. The indirect data as well as the results of the mathematical modelling suggest that the AMP1-like viruses may act as natural biocontrol agents influencing the population levels of B. pseudomallei in soil and water habitats in endemic regions. The cold sensitivity of the lytic growth (CSg) of these phages was suggested to be an important feature modulating the effect of viral infection on host populations in nature. We performed genetic analysis to determine the molecular background of the CSg phenotype of the AMP1 phage. The results indicate that CSg is not due to the lack of any function or product missing at low temperature (25 °C) but results in growth inhibition by a phage-encoded temperature-sensitive genetic switch. We identified phage ORF3 and ORF14 to be involved in the genetic determination of this mechanism.

Indexed as

BacteriophagesBurkholderiaBurkholderia pseudomalleiCaudoviralesMelioidosisHumansPhenotype

Identifiers

PMID35277541
PMCPMC8917201
OpenAlexW4220944432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.